BRPI0816560A2 - Método de inibição de produção de pai-1 método para prevenção ou melhora de uma doença causada por uma super-produção de pai-1" - Google Patents
Método de inibição de produção de pai-1 método para prevenção ou melhora de uma doença causada por uma super-produção de pai-1"Info
- Publication number
- BRPI0816560A2 BRPI0816560A2 BRPI0816560-2A BRPI0816560A BRPI0816560A2 BR PI0816560 A2 BRPI0816560 A2 BR PI0816560A2 BR PI0816560 A BRPI0816560 A BR PI0816560A BR PI0816560 A2 BRPI0816560 A2 BR PI0816560A2
- Authority
- BR
- Brazil
- Prior art keywords
- parent
- production
- amelioration
- prevention
- over
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007275557 | 2007-10-23 | ||
PCT/JP2008/069207 WO2009054439A1 (ja) | 2007-10-23 | 2008-10-23 | Pai-1産生抑制剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0816560A2 true BRPI0816560A2 (pt) | 2015-09-01 |
Family
ID=40579541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0816560-2A BRPI0816560A2 (pt) | 2007-10-23 | 2008-10-23 | Método de inibição de produção de pai-1 método para prevenção ou melhora de uma doença causada por uma super-produção de pai-1" |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2201946A4 (pt) |
JP (1) | JP5470046B2 (pt) |
KR (1) | KR20100097113A (pt) |
CN (2) | CN101842093B (pt) |
AU (1) | AU2008314979A1 (pt) |
BR (1) | BRPI0816560A2 (pt) |
CA (1) | CA2703494A1 (pt) |
RU (1) | RU2010120675A (pt) |
WO (1) | WO2009054439A1 (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011057661A (ja) * | 2009-08-14 | 2011-03-24 | Bayer Cropscience Ag | 殺虫性カルボキサミド類 |
CN104602682B (zh) | 2012-05-08 | 2018-12-14 | 埃罗米克斯公司 | 用于治疗水通道蛋白介导的疾病的化合物 |
CA2929821A1 (en) | 2013-11-06 | 2015-05-14 | Aeromics, Inc. | 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}-4-chlorophenyl dihydrogen phosphate formulations and kits |
JP2017535546A (ja) * | 2014-11-13 | 2017-11-30 | エアロミクス・インコーポレイテッドAeromics,Inc. | 新規な方法 |
US11400142B2 (en) | 2015-12-18 | 2022-08-02 | Talengen International Limited | Treatment of diabetic nerve injury comprising administering plasminogen |
DK3391902T3 (da) | 2015-12-18 | 2023-11-20 | Talengen Int Ltd | Plasminogen til anvendelse i behandlingen af diabetisk angiokardiopati |
CN108463240A (zh) | 2015-12-18 | 2018-08-28 | 泰伦基国际有限公司 | 一种预防或治疗糖尿病性视网膜病变的方法 |
EP3395354B1 (en) | 2015-12-18 | 2024-05-22 | Talengen International Limited | Plasminogen for use in treating diabetic nephropathy |
TW201829448A (zh) | 2016-12-15 | 2018-08-16 | 大陸商深圳瑞健生命科學硏究院有限公司 | 纖溶酶原在製備預防或治療肥胖症及疾病倂發的肥胖的藥物中的用途 |
CN108210895A (zh) * | 2016-12-15 | 2018-06-29 | 深圳瑞健生命科学研究院有限公司 | 预防动脉粥样硬化及其并发症的药物及其用途 |
TWI684459B (zh) | 2016-12-15 | 2020-02-11 | 大陸商深圳瑞健生命科學研究院有限公司 | 一種治療動脈粥樣硬化及其併發症的方法 |
EP3556384B1 (en) | 2016-12-15 | 2024-04-10 | Talengen International Limited | Plasminogen for use in treating diabetes |
CN115504940A (zh) * | 2021-06-23 | 2022-12-23 | 中国科学院上海药物研究所 | 一种酰胺类化合物、其制备方法和制药用途 |
CN113519544A (zh) * | 2021-08-27 | 2021-10-22 | 皖南医学院 | 一种植物源杀螨剂及其制备方法和应用 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1493375A (en) * | 1974-09-20 | 1977-11-30 | Ici Ltd | Salicylanilide derivatives |
IT1196348B (it) * | 1984-11-29 | 1988-11-16 | Italfarmaco Spa | Composti ad attivita'antiinfiammatoria |
GB9402807D0 (en) | 1994-02-14 | 1994-04-06 | Xenova Ltd | Pharmaceutical compounds |
GB9410387D0 (en) | 1994-05-24 | 1994-07-13 | Xenova Ltd | Pharmaceutical compounds |
HUP0102782A3 (en) | 1998-06-19 | 2002-12-28 | Smithkline Beecham Corp | Salycilanilide as inhibitors of transcription factor nf-kb |
AU2002222683B9 (en) | 2000-12-18 | 2021-12-23 | Institute Of Medicinal Molecular Design, Inc | Inflammatory cytokine release inhibitor |
GB2372740A (en) | 2001-01-17 | 2002-09-04 | Xenova Ltd | Diketopiperazines |
WO2003000253A1 (en) | 2001-06-20 | 2003-01-03 | Wyeth | Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
TWI224101B (en) | 2001-06-20 | 2004-11-21 | Wyeth Corp | Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
US7291639B2 (en) | 2001-06-20 | 2007-11-06 | Wyeth | Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
TWI240723B (en) | 2001-06-20 | 2005-10-01 | Wyeth Corp | Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
WO2003100064A1 (fr) | 2002-05-29 | 2003-12-04 | Kyowa Hakko Kogyo Co., Ltd. | Nouvelle ubiquitine-ligase |
WO2003103648A1 (ja) * | 2002-06-05 | 2003-12-18 | 株式会社医薬分子設計研究所 | 糖尿病治療薬 |
TW200407112A (en) | 2002-06-05 | 2004-05-16 | Inst Med Molecular Design Inc | Immunity-related protein kinase inhibitors |
AU2003242098B2 (en) * | 2002-06-10 | 2008-11-20 | Institute Of Medicinal Molecular Design, Inc | Inhibitors against activation of NFkappaB |
JPWO2003103655A1 (ja) * | 2002-06-10 | 2005-10-06 | 株式会社医薬分子設計研究所 | 癌治療剤 |
UA80453C2 (en) | 2002-12-10 | 2007-09-25 | Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
MXPA05006287A (es) | 2002-12-10 | 2005-09-08 | Wyeth Corp | Derivados de acido indoloxo-acetilaminoacetico sustituidos como inhibidores del inhibidor del activador de plasminogeno 1 (pai-1). |
JPWO2005026127A1 (ja) | 2003-09-11 | 2006-11-16 | 株式会社医薬分子設計研究所 | プラスミノゲンアクチベータインヒビター−1阻害剤 |
US7332521B2 (en) | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
US7342039B2 (en) | 2003-09-25 | 2008-03-11 | Wyeth | Substituted indole oximes |
US7442805B2 (en) | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
US7265148B2 (en) | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
US7351726B2 (en) | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
US20050124664A1 (en) | 2003-10-30 | 2005-06-09 | Eric Sartori | Urea thiadiazole inhibitors of plasminogen activator inhibior-1 |
US20050143384A1 (en) | 2003-10-30 | 2005-06-30 | Eric Sartori | Amide thiadiazole inhibitors of plasminogen activator inhibitor-1 |
US20050124667A1 (en) | 2003-10-30 | 2005-06-09 | Eric Sartori | Oxamide inhibitors of plasminogen activator inhibitor-1 |
ES2339138T3 (es) * | 2004-11-24 | 2010-05-17 | Eli Lilly And Company | Derivados de eteres aromaticos utiles como inhibidores de la trombina. |
WO2006095713A1 (ja) * | 2005-03-08 | 2006-09-14 | Institute Of Medicinal Molecular Design. Inc. | プラスミノゲンアクチベータインヒビター-1阻害剤 |
-
2008
- 2008-10-23 CA CA2703494A patent/CA2703494A1/en not_active Abandoned
- 2008-10-23 KR KR1020107010934A patent/KR20100097113A/ko not_active Application Discontinuation
- 2008-10-23 AU AU2008314979A patent/AU2008314979A1/en not_active Abandoned
- 2008-10-23 CN CN2008801133696A patent/CN101842093B/zh not_active Expired - Fee Related
- 2008-10-23 CN CN2012102320448A patent/CN102872020A/zh active Pending
- 2008-10-23 BR BRPI0816560-2A patent/BRPI0816560A2/pt not_active IP Right Cessation
- 2008-10-23 RU RU2010120675/04A patent/RU2010120675A/ru not_active Application Discontinuation
- 2008-10-23 WO PCT/JP2008/069207 patent/WO2009054439A1/ja active Application Filing
- 2008-10-23 EP EP08842108A patent/EP2201946A4/en not_active Withdrawn
- 2008-10-23 JP JP2009538246A patent/JP5470046B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR20100097113A (ko) | 2010-09-02 |
RU2010120675A (ru) | 2011-11-27 |
AU2008314979A1 (en) | 2009-04-30 |
JP5470046B2 (ja) | 2014-04-16 |
EP2201946A4 (en) | 2012-01-25 |
EP2201946A1 (en) | 2010-06-30 |
CN101842093B (zh) | 2012-08-22 |
CA2703494A1 (en) | 2009-04-30 |
WO2009054439A1 (ja) | 2009-04-30 |
JPWO2009054439A1 (ja) | 2011-03-03 |
CN101842093A (zh) | 2010-09-22 |
CN102872020A (zh) | 2013-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0816560A2 (pt) | Método de inibição de produção de pai-1 método para prevenção ou melhora de uma doença causada por uma super-produção de pai-1" | |
BRPI0818799A2 (pt) | Composições para o tratamento da doença de parkinson | |
ZA200808178B (en) | Imidazolothiazole compounds for the treatment of disease | |
BRPI0905680A2 (pt) | "composição farmacêutica de uma composição farmacêutica" | |
FR2906252B1 (fr) | Procede de preparation d'halogenures de n-aklyl naltrexone | |
BRPI0821129A2 (pt) | Métodos para a inibição de cicatrização | |
BRPI0816784A2 (pt) | Fatores neuro-endócrinos para o tratamento de doenças degenerativas | |
FR2917085B1 (fr) | Procede de preparation d'un aldehyde hydroxyaromatique. | |
BRPI0819423A2 (pt) | "lenço auto-indicador para remover bactérias de uma superfície" | |
FI20065089A (fi) | Menetelmä yhdistelmäsuolen valmistamiseksi | |
BR112012015120A2 (pt) | "composição de modificador de vinila melhorada e processos para a utilização da mesma" | |
BRPI1013245A2 (pt) | "composto para o tratamento de distúrbios metabólicos" | |
BRPI0719019A2 (pt) | Sistema de drenagem para uma lavadora de louças | |
BRPI0819037A2 (pt) | "método de fabricar uma bebida" | |
FR2947265B1 (fr) | Procede de preparation d'alkylalcanolamines | |
BRPI0811686A2 (pt) | "método para a produção de sacarídeo, composição de sacarídeo solúvel em água do tipo progut e método para a produção de uma composição de sacarídeo" | |
HU0600198D0 (en) | Duloxetine salts for producing pharmaceutical compositions | |
BRPI0720321A2 (pt) | "método para a produção de uma fralda descartável tipo calça" | |
BRPI0908077A2 (pt) | Composição farmacêutica, métodos para prevenir ou tratar doenças, e para melhorar solubilidade em água de um composto, um sal ou uma pró-droga do mesmo | |
FR2909671B1 (fr) | Procede de preparation de composes 1,3,2-oxazaborolidines | |
FR2902096B1 (fr) | Procede de preparation de dihydroxybenzenedisulfonates metalliques | |
BRPI0914531A2 (pt) | "método para a preparação de um polimorfo a" | |
BRPI1010252A2 (pt) | "prensa para eliminação de água de uma suspensão." | |
BRPI1006618A2 (pt) | "método para inibir a formação de materiais de incrustação" | |
ES1065968Y (es) | Economizador de agua para cuartos de baño |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |